Burn Scar Appearance After Treatment With Fractional Carbon Dioxide (CO2) Laser
Burn Scar Characteristics After Treatment With Fractional CO2 Laser: A Clinical and Histological Study
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to determine if fractional carbon dioxide laser treatment of a burn scar is a more effective method for improving the appearance of scars than the current available treatments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2009
CompletedFirst Posted
Study publicly available on registry
September 1, 2009
CompletedStudy Start
First participant enrolled
December 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedJuly 26, 2011
July 1, 2011
9 months
August 29, 2009
July 24, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evidence of clinical improvement of burn scar appearance as determined by blinded-observer and patient ratings.
2 weeks after each procedure
Study Arms (2)
Laser treatment
EXPERIMENTALHalf of each subject's scar will be treated with a fractional CO2 laser.
No treatment
NO INTERVENTIONHalf of each subject's scar will not be treated.
Interventions
Laser resurfacing of a burn scar
Eligibility Criteria
You may qualify if:
- Have a mature burn scar and desire revision
- Fluent in English
- Must reside in the Los Angeles vicinity for the duration of the study
You may not qualify if:
- Previous history of scar revision
- Non-English speakers
- Pregnant or cognitively impaired subjects
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moy-Fincher Medical Group
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Ozog, MD
Moy-Fincher Medical Group
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 29, 2009
First Posted
September 1, 2009
Study Start
December 1, 2009
Primary Completion
September 1, 2010
Study Completion
December 1, 2010
Last Updated
July 26, 2011
Record last verified: 2011-07